The Stockholm Stock Exchange closed slightly lower on Monday as investors awaited the Federal Reserve's interest rate announcement scheduled for Wednesday evening. Trading was cautious across global markets throughout the day.

At the close, the OMXS30 index was down 0.10 percent at 2,823.91. Shares worth approximately SEK 15.9 billion were traded on the Stockholm Stock Exchange.

Among the major industrial sectors, raw materials posted the best performance with a marginal gain. In contrast, consumer staples ended at the bottom with a 1.4 percent decline.

Among leading stocks included in the OMXS30 index, Saab B rose 1.8 percent while Evolution was up 1.2 percent. H&M B had the weakest performance, falling 1.5 percent, while Essity B dropped 1.3 percent.

EQT shares slipped 0.6 percent. Cosmetics and skincare giant L'Oréal is acquiring an additional 10 percent stake in Germany's Galderma from a consortium led by EQT. With this transaction, L'Oréal increases its ownership in the company to 20 percent.

Surgical simulator company Surgical Science presented new financial targets ahead of Monday's capital markets day, aiming for annual growth of 10-15 percent and an adjusted operating margin of 15 percent. The targets are expected to be met by 2027. The company is also initiating the process to move its listing from First North to the main Nasdaq Stockholm list. The stock fell 2.7 percent.

Pharmaceutical development firm Cinclus Pharma has had its drug linaprazan glurate included on China's national reimbursement list for 2025, paving the way for a broad launch targeting reflux disease in China in 2026. The introduction will take place via partners Jiangsu Sinorda Biomedicine and Huadong Medicine. The stock rose 1.4 percent.

Biopharmaceutical company Bioinvent reported promising early phase 2a results for its monotherapy BI-1808 in the treatment of cutaneous T-cell lymphoma. The treatment was considered well-tolerated and the study will proceed to dose optimization, while a combination study with pembrolizumab continues. The company also released new early safety data for BI-1206. The stock gained 1 percent.

Real estate company Annehem has decided to initiate a share buyback program. The program will cover up to 3 percent of the shares and will run until the annual general meeting in the spring. The stock increased by 6.5 percent.

Industry peer Klarabo is launching a buyback program with a maximum amount of SEK 50 million. The stock declined 0.7 percent.

Gaming company Embracer traded on Monday ex-rights to shares in Coffee Stain, with a 1:1 ratio ahead of the First North listing on December 11. Embracer fell nearly 30 percent.

Handelsbanken believes the market is underestimating steelmaker SSAB's potential and has raised its price target to SEK 101 from SEK 80, while reiterating its buy recommendation. The bank points to changing market dynamics as the EU introduces stricter import rules and carbon tariffs by mid-2026 at the latest, with an expected price increase for hot-rolled plate. SSAB A climbed 2 percent.

SB1 Markets has initiated coverage of Electrolux with a buy recommendation and a price target of SEK 85. The stock rose 0.5 percent.

Atlas Copco was upgraded to overweight by Morgan Stanley, which set a price target of SEK 184. The stock advanced 0.7 percent.

Scandic Hotels was upgraded to buy by UBS, which raised its price target to SEK 101. The stock gained 5.2 percent.

UBS also initiated coverage of Pandox with a buy recommendation and a price target of SEK 220. The stock increased 0.4 percent.

Systemair was upgraded to buy by Nordea, which raised its price target to SEK 110. The stock declined 0.3 percent.

Dagens industri issued a buy recommendation for Inwido. The stock rose 2.3 percent.